These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17671700)

  • 1. Significance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infection.
    Sumie S; Kawaguchi T; Komuta M; Kuromatsu R; Itano S; Okuda K; Taniguchi E; Ando E; Takata A; Fukushima N; Koga H; Torimura T; Kojiro M; Sata M
    Oncol Rep; 2007 Sep; 18(3):545-52. PubMed ID: 17671700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of inositol polyphosphate phosphatase-like 1 associates with unfavorable survival in hepatocellular carcinoma.
    Fu M; Gu X; Ni H; Zhang W; Chang F; Gong L; Chen X; Li J; Qiu L; Shi C; Bao J
    Int J Clin Exp Pathol; 2013; 6(11):2515-22. PubMed ID: 24228114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.
    Lee JJ; Kim PT; Fischer S; Fung S; Gallinger S; McGilvray I; Moulton CA; Wei AC; Greig PD; Cleary SP
    Ann Surg Oncol; 2014 Aug; 21(8):2708-16. PubMed ID: 24806113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
    Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH
    Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection.
    Nakano M; Kawaguchi T; Nakamoto S; Kawaguchi A; Kanda T; Imazeki F; Kuromatsu R; Sumie S; Satani M; Yamada S; Torimura T; Kakuma T; Yokosuka O; Sata M
    Oncol Rep; 2013 Nov; 30(5):2049-55. PubMed ID: 23982634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
    Moya A; Berenguer M; Aguilera V; Juan FS; Nicolás D; Pastor M; López-Andujar R; Rayón M; Orbis F; Mora J; De Juan M; Carrasco D; Vila JJ; Prieto M; Berenguer J; Mir J
    Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of prandial blood glucose and improvement of glucose tolerance by liver-specific inhibition of SH2 domain containing inositol phosphatase 2 (SHIP2) in diabetic KKAy mice: SHIP2 inhibition causes insulin-mimetic effects on glycogen metabolism, gluconeogenesis, and glycolysis.
    Grempler R; Zibrova D; Schoelch C; van Marle A; Rippmann JF; Redemann N
    Diabetes; 2007 Sep; 56(9):2235-41. PubMed ID: 17596404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
    Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental defects and rescue from glucose intolerance of a catalytically-inactive novel Ship2 mutant mouse.
    Dubois E; Jacoby M; Blockmans M; Pernot E; Schiffmann SN; Foukas LC; Henquin JC; Vanhaesebroeck B; Erneux C; Schurmans S
    Cell Signal; 2012 Nov; 24(11):1971-80. PubMed ID: 22750293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COX II and inducible nitric oxide synthase.
    Rahman MA; Kyriazanos ID; Ono T; Yamanoi A; Kohno H; Tsuchiya M; Nagasue N
    Int J Cancer; 2002 Jul; 100(2):152-7. PubMed ID: 12115563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New genetic markers for diagnosis of hepatitis C related hepatocellular carcinoma in Egyptian patients.
    Saad Y; El-Serafy M; Eldin MS; Abdellatif Z; Khatab H; Elbaz T; Elgarem H
    J Gastrointestin Liver Dis; 2013 Dec; 22(4):419-25. PubMed ID: 24369324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A panel of molecular markers in hepatitis C virus-related hepatocellular carcinoma.
    Elgendy SM; Hessien M; Elsherbiny MM; Abd El-Salam IM; El-Attar IA; El-Asser Ael-B
    J Egypt Natl Canc Inst; 2005 Dec; 17(4):270-8. PubMed ID: 17102821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
    Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
    Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2.
    Suwa A; Yamamoto T; Sawada A; Minoura K; Hosogai N; Tahara A; Kurama T; Shimokawa T; Aramori I
    Br J Pharmacol; 2009 Oct; 158(3):879-87. PubMed ID: 19694723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.
    Ueda T; Honda M; Horimoto K; Aburatani S; Saito S; Yamashita T; Sakai Y; Nakamura M; Takatori H; Sunagozaka H; Kaneko S
    Genomics; 2013 Apr; 101(4):238-48. PubMed ID: 23485556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma.
    Chen MF; Jeng LB; Lee WC; Chen TC
    Surgery; 1998 May; 123(5):554-9. PubMed ID: 9591008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the expression of MDR1 in hepatocellular cancer and its biological behaviors.
    Gao B; Yang FM; Yu ZT; Li R; Xie F; Chen J; Luo HJ; Zhang JC
    Int J Clin Exp Pathol; 2015; 8(6):6995-7001. PubMed ID: 26261589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.